RADIOTHERAPY
JUST Leveled Up



Watch video

 

Scintix logo

SCINTIX® technology is a novel therapy for patients with tumors in the lung or bone arising from primary and metastatic cancer. This breakthrough technology uses live, continuously updated data throughout the entire treatment session to determine where to deliver radiotherapy.

DOWNLOAD WHITEPAPER

A BREAKOUT ROLE FOR
RADIOPHARMACEUTICALS

SCINTIX therapy is the only theranostic approach to external-beam radiotherapy that leverages emissions from radiotracers to treat cancer using the individual molecular characteristics of each tumor on the day of treatment.

METASTATIC DISEASE.
GAME ON.

The X1 platform with SCINTIX therapy can treat multiple tumors in the lung or bone in a single plan with conformal dose delivery and potentially smaller margins, resulting in less toxicity that should improve patient outcomes.

MOTION.
MANAGED.

When the tumor moves, the dose moves too. Our SCINTIX technology tracks and shifts the dose in response to both periodic and non-periodic tumor motion caused by physiologic processes, and unexpected motion, like surprise shifts in patient position.

TREAT MULTIPLE TUMORS
THROUGHOUT THE BODY

The X1 platform with SCINTIX therapy treats multiple tumors in a single treatment plan. Hybrid treatments include both SCINTIX and SBRT targets in a single session so clinicians can choose the best therapy for each tumor.

SCINTIX Therapy Overview

SCINTIX therapy and the X1 platform enables clinicians to multiple tumors in a single plan in the same session.

RefleXion Explainer

By combining radiotherapy and PET-CT in a novel way,
we can find and treat cancer using its own emissions.

RefleXion Overview

Learn more about SCINTIX biology-guided radiotherapy and RefleXion’s vision.

SCINTIX Therapy for Metastatic Disease

See how SCINTIX therapy expands radiotherapy to metastatic patients.

Machine Overview

Take a deeper dive into the RefleXion X1 platform.

WHAT IS SCINTIX THERAPY?

SCINTIX THERAPY LIGHTS UP AND TREATS CANCER IN REAL TIME

SCINTIX therapy uses PET – the gold standard in cancer imaging – in a new way to solve the conundrum of targeting and motion management. A single radiopharmaceutical injection turns each cancer into a biological beacon that communicates data about its location, via a continuous stream of emissions.  Onboard PET detectors on the X1 machine sense the emissions and use this data to direct treatment delivery with sub-second latency. The intrafraction PET data display provides added confidence for clinicians that the dose is being delivered as planned.

Watch Video

ADVANCED-STAGE DISEASE

METASTATIC MEET YOUR MATCH

For cancer patients with metastatic disease, the X1 platform enables clinicians to treat multiple tumors in a single plan, optimizing dose for all targets and organs-at-risk simultaneously.  Hybrid treatments, combining SCINTIX and SBRT targets, give clinicians the flexibility to choose the best therapy for each target and deliver that in the same session. By using a tracked dose delivery, the PTV may be more conformal to spare healthy tissue and preserve dose for additional tumors. Together, these capabilities bring the cost effectiveness and efficacy of radiotherapy to more advanced stage patients.

WATCH VIDEO

DISEASE-SPECIFIC RADIOTRACERS

A BREAKTHROUGH ROLE FOR RADIOTRACERS

SCINTIX therapy elevates the performance of radiopharmaceuticals from a diagnostic tool to one that precisely controls treatment delivery, creating a new theranostic approach to external-beam radiotherapy. Currently cleared for use with FDG, RefleXion has forged collaboration and licensing agreements with industry-leading radiopharmaceutical manufacturers to develop  PSMA tracers for prostate cancer, and FAP for treating cancers with a high unmet need. 

WATCH VIDEO

A PERFECT FIT

FIRST AND ONLY DUAL-TREATMENT MODALITY PLATFORM

The RefleXion X1 with SCINTIX therapy is the only hybrid platform offering both biologic technology for tumors in motion and anatomic capabilities via its onboard fan-beam kVCT. The X1 fits in most standard vaults without the need for additional shielding or expensive construction.

WATCH VIDEO

Discover the RefleXion X1 platform.

A closer look at the proprietary technologies that combine to create our game-changing approach to cancer treatment.

Feedback
and
Inquiries.

Let us tell you more.

Contact Us

Sign up for our
latest news and information.

Stay up to date.

Sign Up